Uninterrupted procedure (n=34) | Standart procedure (n=28) | p | |
---|---|---|---|
Mobilization n(%) G-CSF G-CSF+Plerixofar | 19 (67.9) 9(32.1) | 19(55.9) 15(44.1) | NS |
İnfused CD34+ cell (medianx10e6/kg) | 4.5 (3.3-6.2) | 4(3.0-5.4) | NS |
Day of neuthrophil engraftment (median day) | 12(8-17) | 12(11-18) | NS |
Day of platelet engraftment (median day) | 13(8-22) | 12(10-20) | NS |
Transfusion requirement (median U) Erytrocyte Platelet | 1(1-8) 3(1-8) | 1(0-7) 2(0-9) | NS |
Catheter infection n(%) | 2(5.8) | 2(7.1) | NS |
Febril neuthropenia n(%) | 13(38.2) | 13(46.4) | NS |
Engraftment syndrome n(%) | 4(11.7) | 8(28.5) | NS |
Graft dysfunction n(%) | 2 (5.8) | 3 (10.7) | NS |